Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter J Goebell

Showing results (41-50 of 107) with videos related to

Pageof 11
Sort By:
Urologic Oncology|July 9, 2010
Statistical consideration for clinical biomarker research in bladder cancerShahrokh F Shariat, Yair Lotan, Andrew Vickers, et al.
Der Urologe. Ausg. A|December 21, 2020
[Advanced prostate cancer: sequence of androgen receptor-targeted substances and chemotherapy determines long-term survival]Christian Wülfing, Peter J Goebell, Rolf Eichenauer, et al.
Journal of Cancer Research and Clinical Oncology|April 2, 2025
Improving quality of care for cancer patients through oncological second opinions in a Comprehensive Cancer Center: adherence to second-opinion therapy recommendationsCarla Schulmeyer, Peter A Fasching, Matthias W Beckmann, et al.
Urologie (Heidelberg, Germany)|August 1, 2023
[Individualized precision medicine]Bernd Wullich, Helge Taubert, Peter J Goebell, et al.
Urologic Oncology|January 27, 2019
Editorial: Basic research in bladder cancer - refining the tools. 3rd IBCN seminars series<sup>1</sup>Peter C Black, Peter J Goebell, Ashish M Kamat, et al.
BMC Urology|October 26, 2013
Bladder cancer--the neglected tumor: a descriptive analysis of publications referenced in MEDLINE and data from the register ClinicalTrials.govFrank Kunath, Steffen F Krause, Bernd Wullich, et al.
Urologic Oncology|August 5, 2019
Editorial: Bladder cancer within the focus of basic and clinical research. Sixth IBCN Seminars SeriesRoland Seiler, Peter C Black, Stephen B Williams, et al.
Urologic Oncology|August 4, 2014
Comparative genomic hybridization shows complex genomic changes of plasmacytoid urothelial carcinomaBastian Keck, Christina Ellmann, Robert Stoehr, et al.
Annals of Surgical Oncology|June 29, 2013
SNAI1 protein expression is an independent negative prognosticator in muscle-invasive bladder cancerBastian Keck, Sven Wach, Peter J Goebell, et al.
European Urology|September 10, 2013
Temsirolimus in daily use: results of a prospective multicentre noninterventional study of patients with metastatic kidney cancerAndres Jan Schrader, Sandra Seseke, Christian Keil, et al.
Pageof 11

Showing results (41-50 of 107) with videos related to

Sort By:
Pageof 11
Urologic Oncology|July 9, 2010
Statistical consideration for clinical biomarker research in bladder cancerShahrokh F Shariat, Yair Lotan, Andrew Vickers, et al.
Der Urologe. Ausg. A|December 21, 2020
[Advanced prostate cancer: sequence of androgen receptor-targeted substances and chemotherapy determines long-term survival]Christian Wülfing, Peter J Goebell, Rolf Eichenauer, et al.
Journal of Cancer Research and Clinical Oncology|April 2, 2025
Improving quality of care for cancer patients through oncological second opinions in a Comprehensive Cancer Center: adherence to second-opinion therapy recommendationsCarla Schulmeyer, Peter A Fasching, Matthias W Beckmann, et al.
Urologie (Heidelberg, Germany)|August 1, 2023
[Individualized precision medicine]Bernd Wullich, Helge Taubert, Peter J Goebell, et al.
Urologic Oncology|January 27, 2019
Editorial: Basic research in bladder cancer - refining the tools. 3rd IBCN seminars series<sup>1</sup>Peter C Black, Peter J Goebell, Ashish M Kamat, et al.
BMC Urology|October 26, 2013
Bladder cancer--the neglected tumor: a descriptive analysis of publications referenced in MEDLINE and data from the register ClinicalTrials.govFrank Kunath, Steffen F Krause, Bernd Wullich, et al.
Urologic Oncology|August 5, 2019
Editorial: Bladder cancer within the focus of basic and clinical research. Sixth IBCN Seminars SeriesRoland Seiler, Peter C Black, Stephen B Williams, et al.
Urologic Oncology|August 4, 2014
Comparative genomic hybridization shows complex genomic changes of plasmacytoid urothelial carcinomaBastian Keck, Christina Ellmann, Robert Stoehr, et al.
Annals of Surgical Oncology|June 29, 2013
SNAI1 protein expression is an independent negative prognosticator in muscle-invasive bladder cancerBastian Keck, Sven Wach, Peter J Goebell, et al.
European Urology|September 10, 2013
Temsirolimus in daily use: results of a prospective multicentre noninterventional study of patients with metastatic kidney cancerAndres Jan Schrader, Sandra Seseke, Christian Keil, et al.
Pageof 11